Biomarker
How the IHMED Reproductive Center Improves Infertility Outcomes by Targeting Immune Response
2022-04-19Partner
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
Memorial Sloan Kettering AI spinout Partners with a Fortune 500 Company to Advance AI-powered Cancer Diagnosis
2021-05-28
Roche Forays into Syndromic Panel Testing by Placing $1.8 Billion Bet on GenMark Acquisition
2021-03-15
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115